MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Postural deformities in Chinese patients with multiple system atrophy

    L. Zhang, B. Cao, Y. Zou, Q. Wei, R. Ou, B. Zhao, J. Yang, Y. Wu, H. Shanng (Chengdu, China)

    Objective: The objective of our study was to investigate the frequency and clinical characteristics of the postural deformities in Chinese patients with multiple system atrophy…
  • 2018 International Congress

    An atutopsy case of argyrophilic grain disease, clinically presenting with Parkinson dementia

    R. Sengoku, D. Kaneda, M. Kameyama, A. Tokumaru, K. Ishii, K. Kanemaru, Y. Saito, S. Murayama (Tokyo, Japan)

    Objective: We here reported argyrophilic grain disases (AGD) with clinical diagnosis of Parkinson dementia. Background: AGD is a four-repeat tauopathy and its accumulation (argyrophilic grain…
  • 2018 International Congress

    Burden among Patients with Progressive Supranuclear Palsy

    T. Xie, X. Ye, L. Kandukuri, Y. Bao (Chicago, IL, USA)

    Objective: To quantify the economic costs and examine the most common co-morbidities of patients with progressive supranuclear palsy (PSP) in the United States. Background: PSP…
  • 2018 International Congress

    Serum insulin-like growth factor-1 levels in parkinsonism or dementia disorders

    K. Suzuki, S. Suzuki, Y. Ishii, T. Matsubara, H. Fujita, Y. Watanabe, M. Okamura, T. Kadowaki, H. Sakuramoto, K. Hirata (Tochigi, Japan)

    Objective: To investigate serum insulin growth factor-1 (IGF-1) levels in neurodegenerative disease and to correlate clinical parameters. Background: IGF-1 is highly expressed in the central…
  • 2018 International Congress

    Nilotinib for treating MSA: A preclinical proof of concept study

    P. Guerin, M. Lopez-Cuina, E. Bezard, W. Meissner, P-O. (Bordeaux, France)

    Objective: To assess the effects of nilotinib on motor behavior, α-synuclein burden and surrogate markers of neurodegeneration in a transgenic mouse model of multiple system…
  • 2018 International Congress

    Accuracy of the International Parkinson Disease and Movement Disorder Society Progressive Supranuclear Palsy Diagnostic Criteria (IPD-MDS-PSP)

    A. Shoeibi, I. Litvan, J. Juncos, Y. Bordelon, D. Riley, S. Reich, D. Shprecher, D. Hall, C. Marras, B. Kluger, N. Olfati, J. Jankovic (Mashhad, Islamic Republic of Iran)

    Objective: To evaluate the accuracy of the IPD-MDS-PSP criteria to differentiate PSP-Richardson (PSP-R) from PSP-parkinsonism (PSP-P), the most common PSP phenotypes. Background: The new International…
  • 2018 International Congress

    Methylphenidate in Progressive Supranuclear Palsy [PSP] – Old drug, New Indications?

    N. Sawal, P. Bansal, R. Gupta (Chandigarh, India)

    Objective: To evaluate whether Methylphenidate can improve some symptoms of PSP. Background: PSP is a neurodegenerative disorder with limited therapeutic options. Methylphenidate[MPH] , a drug…
  • 2018 International Congress

    Vascular parkinsonism: Clinical features and comparison with Parkinson’s disease

    C. Simonet, A. Garrido, F. Valldeoriola, MJ. Martí, Y. Compta (Barcelona, Spain)

    Objective: To define the clinical features of vascular parkinsonism (VP) and compare it to idiopathic Parkinson’s disease (iPD). Background: The main differential diagnosis of VP…
  • 2018 International Congress

    The Timed Up & Go test (time) is inversely associated with fall frequency in progressive supranuclear palsy

    N. Matsuda, Y. Takamatsu, I. Aiba (Nagoya, Japan)

    Objective: This study aimed to elucidate the appropriate assessments associated with fall frequency in progressive supranuclear palsy (PSP). Background: PSP is an adult-onset neurodegenerative disease,…
  • 2018 International Congress

    Atypical Response to Apomorphine in a Patient with Multiple System Atrophy

    S. Ozben, F. Genc, F. Tuter Yilmaz, A. Erdal, N. Atis (Antalya, Turkey)

    Objective: Multiple system atrophy (MSA) is a sporadic neurodegenerative disease clinically characterized by cerebellar signs, parkinsonism and autonomic dysfunction. MSA is classified into two sub-types;…
  • « Previous Page
  • 1
  • …
  • 1107
  • 1108
  • 1109
  • 1110
  • 1111
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #23660 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley